{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:01:42Z","timestamp":1768899702074,"version":"3.49.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"abstract":"<jats:p>\n                    There are differing clinical perspectives on the resection range of transurethral resection of bladder tumor (TURBT) for paraureteral bladder cancer. This study aimed to compare the incidence of ureteral stricture and bladder cancer recurrence after conservative versus aggressive TURBT in the treatment of paraureteral bladder cancer. A retrospective analysis was performed on 164 patients with paraureteral bladder cancer who underwent TURBT between April 2017 and July 2024. Among them, 133 patients had complete clinical and follow-up data. Based on the resection margin of the tumor, patients were divided into the conservative group and the aggressive group. The 2 groups were compared regarding the outcomes of postoperative ureteral stricture and bladder cancer recurrence. The overall incidence of ureteral stricture within 1 year after TURBT was 11.28% (15\/133), and the recurrence rate of bladder cancer was 21.80% (29\/133). All patients had negative postoperative resection margins and no deaths within 1 year. The incidence of postoperative ureteral stricture was 11.11% (6\/54) in the conservative treatment group and 11.39% (9\/79) in the aggressive treatment group, with no statistically significant difference between the 2 groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.960). The postoperative recurrence of bladder cancer was 31.48% (17\/54) in the conservative treatment group and 15.19% (12\/79) in the aggressive treatment group, and there was a statistically significant difference between the 2 groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.025). Aggressive TURBT for paraureteral bladder cancer showed no significant difference in the incidence of postoperative ureteral stricture compared with conservative TURBT but significantly reduced the recurrence rate of bladder cancer. Therefore, we believe that during TURBT for paraureteral bladder cancer, maximizing the resection range, including a wider safety margin (&gt;1\u2009cm) around the main tumor \u2013 may be more appropriate.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047176","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:01:26Z","timestamp":1768849286000},"page":"e47176","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Conservative versus aggressive transurethral resection of bladder cancer for paraureteral bladder cancer: A comparison of postoperative ureteral stricture and cancer recurrence rates"],"prefix":"10.1097","volume":"105","author":[{"given":"Dongdong","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Urology, Peking University First Hospital - Miyun Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0359-9123","authenticated-orcid":false,"given":"Rui","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Urology, YuQuan Hospital, Tsinghua University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Urology, YuQuan Hospital, Tsinghua University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Urology, YuQuan Hospital, Tsinghua University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260119","first-page":"15","article-title":"Epidemiology of bladder cancer.","volume":"8","author":"Saginala","year":"2020","journal-title":"Med Sci (Basel)"},{"key":"R2-20260119","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer.","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"R3-20260119","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.diff.2018.08.004","article-title":"Development of the human bladder and ureterovesical junction.","volume":"103","author":"Liaw","year":"2018","journal-title":"Differentiation"},{"key":"R4-20260119","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/21681805.2015.1066849","article-title":"Tumour location adjacent to the ureteric orifice in primary Ta\/T1 bladder cancer is predictive of recurrence.","volume":"50","author":"Jancke","year":"2016","journal-title":"Scand J Urol"},{"key":"R5-20260119","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/iju.15263","article-title":"Recent advancements in the diagnosis and treatment of non-muscle invasive bladder cancer: evidence update of surgical concept, risk stratification, and BCG-treated disease.","volume":"30","author":"Miyake","year":"2023","journal-title":"Int J Urol"},{"key":"R6-20260119","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1464-410X.2005.05928.x","article-title":"The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives.","volume":"96","author":"V\u00f6geli","year":"2005","journal-title":"BJU Int"},{"key":"R7-20260119","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"R8-20260119","doi-asserted-by":"crossref","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer.","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"issue":"Suppl 1","key":"R9-20260119","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.4111\/icu.2016.57.S1.S44","article-title":"How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?","volume":"57","author":"Yun","year":"2016","journal-title":"Investig Clin Urol"},{"key":"R10-20260119","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MOU.0000000000000548","article-title":"A risk-stratified approach to the management of high-grade T1 bladder cancer.","volume":"28","author":"Mannas","year":"2018","journal-title":"Curr Opin Urol"},{"key":"R11-20260119","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ).","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"R12-20260119","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1097\/JS9.0000000000001675","article-title":"The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registries.","volume":"110","author":"Liu","year":"2024","journal-title":"Int J Surg"},{"key":"R13-20260119","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1007\/s12032-011-9999-4","article-title":"Prognostic significance of tumor location in high-grade non-muscle-invasive bladder cancer.","volume":"29","author":"Vukomanovic","year":"2012","journal-title":"Med Oncol"},{"key":"R14-20260119","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s12885-022-09733-8","article-title":"Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor.","volume":"22","author":"Jeong","year":"2022","journal-title":"BMC Cancer"},{"key":"R15-20260119","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1464-410X.2011.10571.x","article-title":"Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.","volume":"109","author":"Mariappan","year":"2012","journal-title":"BJU Int"},{"key":"R16-20260119","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/21681805.2019.1604568","article-title":"Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations: effect of a prospective intervention in primary bladder cancer patients.","volume":"53","author":"S\u00f6renby","year":"2019","journal-title":"Scand J Urol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:01:28Z","timestamp":1768849288000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047176","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"2025-08-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}